Literature DB >> 25703457

Morality in a time of Ebola.

Arthur L Caplan1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25703457     DOI： 10.1016/S0140-6736(14)61653-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Ethics of trial drug use: to give or not to give?

Authors:  Oduwole O Ebunoluwa; Fayemi A Kareem
Journal:  BEOnline       Date:  2016-11-22

2.  Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials.

Authors:  Carole A Federico; Patrick J Heagerty; John Lantos; Pearl O'Rourke; Vasiliki Rahimzadeh; Jeremy Sugarman; Kevin Weinfurt; David Wendler; Benjamin S Wilfond; David Magnus
Journal:  Contemp Clin Trials       Date:  2022-02-15       Impact factor: 2.261

Review 3.  Critical role of ethics in clinical management and public health response to the West Africa Ebola epidemic.

Authors:  Morenike O Folayan; Bridget G Haire; Brandon Brown
Journal:  Risk Manag Healthc Policy       Date:  2016-05-12

4.  Ebola vaccine development plan: ethics, concerns and proposed measures.

Authors:  Morenike Oluwatoyin Folayan; Aminu Yakubu; Bridget Haire; Kristin Peterson
Journal:  BMC Med Ethics       Date:  2016-02-08       Impact factor: 2.652

5.  Ethical considerations surrounding the response to Ebola: the Spanish experience.

Authors:  Miguel Ángel Royo-Bordonada; Fernando J García López
Journal:  BMC Med Ethics       Date:  2016-08-18       Impact factor: 2.652

Review 6.  Marginalisation, Ebola and Health for All: From Outbreak to Lessons Learned.

Authors:  Clare Shelley-Egan; Jim Dratwa
Journal:  Int J Environ Res Public Health       Date:  2019-08-21       Impact factor: 3.390

7.  The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial.

Authors:  Phaik Yeong Cheah; Norbert Steinkamp; Lorenz von Seidlein; Ric N Price
Journal:  BMC Med Ethics       Date:  2018-03-06       Impact factor: 2.652
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.